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Context. The Palliative care Outcome Scale (POS) and the Support Team Assessment Schedule (STAS) are two outcome
measures used in palliative care settings to assess palliative concerns, needs, and quality of care.
Objectives. This systematic review builds on the findings of a previous review to appraise the use of the POS and STAS since
2010, particularly the context and nature of their use.
Methods. MEDLINE, Embase, PsycINFO, British Nursing Index, and CINAHL were searched for studies published
between February 2010 and June 2014. Relevant authors were contacted, and reference lists of included studies were searched.
Studies reporting validation or the use of the POS or STAS were included, and data on sample population, how the outcome
measure was being used, study design, study aim, and results of the study were extracted.
Results. Forty-three studies were included (POS n ¼ 35, STAS n ¼ 8). There was an increase in the use of the POS and
STAS in Europe and Africa with the publication of 13 new translations of the POS. Most studies focused on the use, rather
than further validation, of the POS and STAS. There has been increasing use of these measures within nonecancer patient
groups.
Conclusion. The POS and STAS are now used in a wide variety of settings and countries. These tools may be used in the
future to compare palliative care needs and quality of care across diverse contexts and patient groups. J Pain Symptom
Manage 2015;50:842e853  2015 The Authors. Published by Elsevier Inc. on behalf of American Academy of Hospice and
Palliative Medicine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Outcome measures have an increasingly important
role in health care. These are measures that help to re-
cord a patient’s change in health over time, as a result
of health care or interventions.1 The implementation
of outcome measures is important for improving the
quality of service delivery and promoting account-
ability. In particular, patient-reported outcome mea-
sures (PROMs or PROs) are increasingly recognized
as a good way to inform the delivery of health careAddress correspondence to: Fliss E. M. Murtagh, PhD, Depart-
ment of Palliative Care, Policy and Rehabilitation, Cicely Sa-
unders Institute, King’s College London, Bessemer Road,
London SE5 9PJ, UK. E-mail: fliss.murtagh@kcl.ac.uk
 2015 The Authors. Published by Elsevier Inc. on behalf of American
Academy of Hospice and Palliative Medicine. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).and promote patient-centered care, as outcomes
directly reflect the difference made for the patient.2
The Support Team Assessment Schedule (STAS)
and the Palliative care (or Patient) Outcome Scale
(POS) are examples of outcome measures specifically
developed for palliative care. The STAS was developed
in 1986 as a standardized measure to evaluate the work
of palliative care support teams. Its 17 items can be
rated from 0 (best) to 4 (worst) by a patient’s profes-
sional caregiver. These items measure patientAccepted for publication: July 13, 2015.
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insight, quality of communication with health care
professionals and carers, and the need for practical
support. Cohen kappas for STAS items were greater
than 0.48 (up to 0.87), with high correlation coeffi-
cients (Spearman rho ranged 0.65e0.94).3,4
The POS was developed in 1999 following the suc-
cess of the STAS. This measure was designed for use
with advanced cancer patients and evaluates similar
outcomes to the STAS, but with an additional
patient-reported element. The POS demonstrated
good construct validity (Spearman rho ¼ 0.43e0.80),
as well as test/retest reliability.5 Internal consistency
of the different versions of the measure was also
good (Cronbach alpha ¼ 0.65 [patients], 0.70
[staff]).5 The 10 items of the POS assess physical symp-
toms, psychological, emotional, and spiritual needs,
and the provision of information and practical sup-
port. Two versions of the original (‘‘core’’) POS are
available for use in specialist and nonspecialist pallia-
tive care settings. The latter is also referred to as the
‘‘Patient Outcome Scale’’ in some studies.6 This is rec-
ommended when POS is used in a population that will
not necessarily be familiar with or introduced to the
term palliative care, such as screening those with
long-term conditions for palliative care needs.
The POS-S is a further development of the POS that
incorporates a symptom list. Extended versions of
the POS-S have been developed for use with those
living with multiple sclerosis (POS-S-MS), parkinson
disease (POS-S-PP), and end-stage renal disease
(POS-S-renal). Additional POS measures (POS-S and
Integrated Palliative care Outcome Scale [IPOS])
represent refinements of POS to capture more detail
about symptoms (POS-S) or to integrate the core
POS with the symptom module POS-S (IPOS). In addi-
tion, POS is being developed as a screening measure
to assess needs of dementia patients residing in care
homes.
One of the main challenges to the use of PROMs in
palliative care is the high proportion of palliative care
patients with impaired cognition or those who are
otherwise too unwell to complete them. In some palli-
ative care settings, nearly 60% of all patients were un-
able to complete PROMs unaided.7 It is helpful,
therefore, to use the term ‘‘patient-centered outcome
measures,’’8 which refers to measures that encapsulate
the priorities of patients themselves, but may include
proxy reporting (i.e., they are completed with help
from family or professionals, or directly by profes-
sionals themselves). Of note, the POS exists in patient,
health professional, and carer versions, and so sup-
ports this approach.
A review was conducted in 2010 to appraise the use
of the POS and STAS since their development. Tobuild on these findings, the present review aims to
appraise the use of the POS and STAS, especially in
the context and nature of their use and identify
strengths and weaknesses, by identifying and analyzing
publications about their use since 2010.Methods
Design
We conducted a systematic literature review to up-
date the previous review by Bausewein et al.,7 including
references up to 2014. We followed standard review
methodologies as outlined by the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis (PRIS-
MA) statement, which is an evidence-based minimum
set of items for reporting systematic reviews.9,10
Search Strategy
We used a predefined search strategy. Articles were
identified by a comprehensive search of five electronic
databases: MEDLINE, Embase, PsycINFO, British
Nursing Index, and CINAHL. Databases were
searched for articles published between January 1,
2010 and June 9, 2014. The following search terms
were used in an advanced key word search, or an
advanced abstract search where the key word search
function was unavailable: ‘‘Support Team Assessment
Schedule’’; ‘‘STAS and palliative’’; ‘‘Palliative Care
Outcome Scale’’; ‘‘Palliative Outcome Scale’’; ‘‘Patient
Outcome Scale’’; and ‘‘POS and palliative.’’ To identify
any further articles, the reference lists of relevant arti-
cles were reviewed, users registered to the POS website
(www.pos-pal.org) were contacted for additional publi-
cations, and a list of publications from the Depart-
ment of Palliative Care, Policy and Rehabilitation,
King’s College London, was searched for relevant re-
cords from 2010 onward. Full details of the search
strategy are presented in Appendix I (available at
jpsmjournal.com).
Inclusion and Exclusion Criteria
Inclusion criteria were as follows: 1) those publica-
tions that focused on the validation of POS (and
related measures, e.g., POS-S) or STAS; 2) reported
psychometric testing or psychometric properties of
the original measures or of translations; and 3) those
publications that used the POS (and related mea-
sures, e.g., POS-S) or STAS to collect data. Exclusion
criteria were as follows: 1) review articles; 2) publica-
tions before January 2010; and 3) publications already
included in the previous review.7
Study Selection
Studies identified through the search were imported
into Endnote X7 (Thomson Reuters, Philadelphia,
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stracts, reviews, and research agendas. The abstracts of
the remaining studies were assessed, with eligible
studies being further subjected to full-text screening
before being included in the systematic review.
Data Extraction and Analysis
Data were extracted from included studies and tabu-
lated in a spreadsheet. Data captured included year of
publication, author, study location/country, sample
population, how the outcome measure was being
used, study design, study aim, and results of the study.
Details are in Appendix II (available at jpsmjournal.
com). Articles were then categorized by their main
objective and purpose of the use of the outcome mea-
sure, for example, study of symptom prevalence within
a population. Details are in Appendix III (available at
jpsmjournal.com). Both of these processes were car-
ried out by one researcher (E. C.) independently,
with the process repeated for 10% of studies by
another independent researcher (J. W.). Raters agreed
on 68% of items. Any discrepancies were discussed
with the senior authors until agreement was reached.
Data Synthesis
Extracted data from the studies were tabulated by
classification according to their main objective. Data
were then further synthesized into tables to show
countries, translations, and populations in which the
measures were used. These data were reported inde-
pendently and in total with the data reported in the
previous review by Bausewein et al.7Results
Study Selection
Overall, 178 articles were identified from the data-
base search, and 10 additional articles were identified
through contacts, scanning of reference lists, and
departmental publications (Fig. 1). After exclusion
of duplicates and nonrelevant articles, 43 studies re-
mained: 35 on one of the POS family of measures
and eight on the STAS. Characteristics of the included
studies may be found in Appendices II and III (avail-
able at jpsmjournal.com).
In addition, we were made aware of four ongoing
studies that used or validated the POS, but these
would not be ready for publication until after the pub-
lication of this review. Details of these studies can be
found in Appendix IV (available at jpsmjournal.com).
Study Designs and Aims
Of the 35 POS studies included, 24 were
observational6,11e33 and 11 were experimental.34e44
Of the observational studies, 10 were cross-sectional,6,13,15,16,20,21,23,25,31,32 11 were longi-
tudinal,11,12,17e19,22,26,27,29,30,33 two were qualitative
or mixed methods,24,28 and one was of part of a qual-
ity assurance program.14 Of the experimental
studies, three were randomized controlled trials
(RCTs)37,38,43 and the remainder were quasi-
experimental.34e36,39e42,44
Of the eight STAS studies included, seven were
observational45e51 and one was experimental.52 Of
the observational studies, two were cross-sectional45,46
and five were longitudinal.47e51 The experimental
study was longitudinal.52 A total of 8728 palliative
care patients contributed data to the included POS
and STAS studies.Population
Both POS and STAS measures can be applied for a
variety of diagnoses. As depicted in Table 1, these tools
have both been used predominantly with cancer pa-
tients, but also with populations with HIV/AIDS. Since
the previous review, STAS has only been applied to
cancer patients45e48,50e52 and those with unspecified
palliative care needs.49 In contrast, the POS has
been applied not only for cancer,11,15,21,30,36,39,40,44
but also for a range of additional diagnoses; HIV/
AIDS,16,17,25,31,32,34,38,43 dementia,13,27 MS,26,37 Parkin-
son disease,18,23 chronic kidney disease,6,33 chronic
heart failure,29,38 and chronic obstructive pulmonary
disease (COPD).11,30 Although the POS was used
with some of these patient populations at the time
of the previous review, it has now been used in a num-
ber of new populations, in subgroups, or at different
stages of disease: renal transplant patients,6 end-
stage renal disease,33 Parkinson syndromes (idiopathic
Parkinson disease, progressive supranuclear palsy, and
multiple system atrophy),23,37 newly diagnosed HIV
patients,25 patients severely affected by MS,26 and
advanced COPD.30
Whereas the STAS was developed to be used by
health care professionals to assess patients, the POS
was developed from the outset to have a patient and
a staff version. One study using the STAS did involve
informal carers; this was an audit of a telephone triage
service used by patients, caregivers, and health profes-
sionals, which used a modified version of the STAS.49
Two studies investigated the effect of a palliative care
training intervention for health care profes-
sionals.36,41 The POS was completed by health care
professionals and informal caregivers as a retrospec-
tive analysis of decedents with dementia,27 whereas
three other similar studies used only caregiver assess-
ments.13,15,44 Four studies incorporated caregiver
views on the experience of caring or of palliative
care services, and on their views of patients’
experiences.21,29,35,41
IdenƟficaƟon
Screening
Eligibility
Included
178 records idenƟfied 
through database searching
5 departmental 
publicaƟons
Title screening of 188 records
Abstract screening of 99 records
89 records excluded.
Duplicate = 38
Conference abstract = 32
Review = 13
Research agenda = 1
Before Feb. 2010 and included in previous review = 5
Full-text screening of 57 records
15 Full-text records excluded.
POS used to validate another measurement tool = 3
Found to be included in previous review = 2
EvaluaƟon/review = 2
Conference abstract = 1
Duplicate = 1
No validaƟon or use of POS = 5
Ongoing, unpublished study = 1
42 records
8 publicaƟons on 
STAS
35 publicaƟons on 
POS
42 records excluded.
POS/STAS not used = 36
Commentary = 1
Review = 4
Before Feb. 2010 and included in previous review = 1
5 publicaƟons submiƩed 
by POS users
43 included studies
1 record from scanning reference lists
Fig. 1. PRISMA chart for identifying publications on POS and STAS. POS ¼ Palliative care Outcome Scale; PRISMA ¼
Preferred Reporting Items for Systematic Reviews and Meta-Analysis; STAS ¼ Support Team Assessment Schedule.
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In addition to the original versions of the POS and
STAS, several different versions and adaptations were
used throughout studies. The POS-S has been used
alongside the core POS to assess patients with breath-
lessness,21 although some studies used the extended
versions of the POS-S; POS-S-PP,18,23 POS-S-MS,26
and POS-S-renal.6 The study using POS-S-renal6
added nine items to the scale to capture additional
symptoms in a renal transplant population, whereas
a study assessing heart failure and lung cancer pa-
tients21 used the core POS with POS-S, with the addi-
tion of two items from POS-S-PP. There were 12studies reporting use of the African Palliative Care
Association (APCA) African POS,14,16,17,19,20,
24,25,31,32,34,38,43 in comparison to just two in the previ-
ous review.
The STAS was originally developed as a 17-item
score. A version that was adapted and validated for
inpatient use53 was used in Hong Kong.45 The STAS
was further adapted with additional symptom detail
for use in a telephone triage service for palliative
care patients in the UK.49 Conversely, one study in
Japan51 condensed the scale to use only the second
item for assessing symptom control after radiation
therapy.
Table 1
Classification of Studies by Sample Population
Palliative Care Patients With
STAS (Total Studies
n ¼ 47)
POS (Total Studies
n ¼ 79)
STAS (New Studies
n ¼ 8)
POS (New Studies
n ¼ 35)
Cancer 30 28 7 8
Mixed diagnosesdpalliative population (not specified) 9 18 1 8
HIV/AIDS 4 12 0 8
Neurological disease 1 11 0 6
Chronic kidney disease 0 3 0 2
Chronic heart failure 1 3 0 2
Chronic obstructive pulmonary disease 0 3 0 2
Studies that included formal/informal carers (with/without patients)
Health care professionals 3 8 1 3
Health care professionals (with patients) 1 9 0 3
Informal/family carers 1 7 1 6
Informal/family carers (with patients) 0 6 0 3
STAS ¼ Support Team Assessment Schedule; POS ¼ Palliative care Outcome Scale.
Some studies had more than one population and were counted more than once.
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There have been numerous translations of the STAS
and POS (Table 2), with several new POS translations
becoming available since the last review. All new POS
translations are versions of the APCA African POS,54
which was formally translated and partially validated
in various African languages: isiXhosa,16,24,38
isiZulu,16,24 Luganda,16,24,25 Runyankole,16
Runyoro,16,24 SeSotho,16,24 and SeTswana.16,24 FurtherTable
Validation/Use of Translat
Language
STAS
Translation
Available
Articles on
Validationa Article
Afrikaans 0
Dutch U 0
Chinese (Mandarin) U 0
French Uc 0
German 0
isiXhosa 0
isiZulu 0
Italian Uc 0
Japanese U 0
Khmer 0
KwaZulu Natal dialects 0
Luganda 0
Luo 0
Malayalam 0
Polish U 0
Portuguese 0
Punjabi 0
Runyakitara 0
Runyankole 0
Runyoro 0
SeSotho 0
SeTswana 0
Spanish U 0
Swahili 0
Tumbuka 0
Urdu 0
STAS ¼ Support Team Assessment Schedule; POS ¼ Palliative care Outcome Scal
aSince 2010 only; refer to Appendix II for a list of articles and translation used.
bNew since last review.
cFormally validated.translated versions in Afrikaans,38 KwaZulu Natal dia-
lects,16 Luo,25 Runyakitara,25 Swahili,17,25,38 and Tum-
buka43 also are available and/or in use; however, these
have not yet been validated. No new translations of the
STAS were published, nor any validations of previous
translations.
New studies using the STAS or POS have a broad
geographical scope (Table 3), with the number of
studies from Africa rivaling that of Europe. All2
ions of STAS and POS
POS
s on Usea
Translation
Available
Articles on
Validationa Articles on Usea
0 Ub 0 1
0 Uc 2 1
2 U 0 0
1 U 0 0
0 Uc 0 4
0 Ub,c 1 2
0 Ub,c 1 1
0 U 0 1
4 0 0
0 U 0 0
0 Ub 0 1
0 Ub,c 1 2
0 Ub 0 1
0 Uc 0 0
0 0 0
0 Uc 0 0
0 U 0 0
0 Ub 0 1
0 Ub,c 0 1
0 Ub,c 1 1
0 Ub,c 1 1
0 Ub,c 1 1
0 Uc 1 2
0 Ub 0 3
0 Ub 0 1
0 Uc 0 0
e.
Table 3
Locations Where Data Using STAS and POS Have Been Collected
Continent Country
STAS (Total Studies
n ¼ 47)
POS (Total Studies
n ¼ 79)
STAS (New Studies
n ¼ 8)
POS
(New Studies
n ¼ 35)
Europe U.K. 16 34 1 9
Belgium 1 0 0 0
Denmark 0 1 0 0
France 3 1 1 0
Germany 0 9 0 4
Ireland 2 0 0 0
Italy 3 1 0 1
The Netherlands 0 4 0 3
Poland 2 0 0 0
Portugal 0 1 0 0
Spain 1 4 0 3
Asia China 5 0 2 0
Japan 13 0 4 0
India 0 1 0 0
Singapore 0 1 0 0
Cambodia/Dominican Republic 0 1 0 0
North America U.S. 0 4 0 3
Canada 1 0 0 0
Latin America Argentina 0 1 0 0
Cuba 0 1 0 0
Africa Africa 0 3 0 0
Kenyaa 0 4 0 4
Malawia 0 1 0 1
South Africaa 0 6 0 6
Tanzaniaa 0 1 0 1
Ugandaa 0 5 0 5
Zimbabwea 0 1 0 1
STAS ¼ Support Team Assessment Schedule; POS ¼ Palliative care Outcome Scale.
aNew since last review.
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in many regions of the world, including Europe, Asia,
North America, Latin America, and Africa, with the
exception of Australia and New Zealand. STAS use re-
mains popular in China and Japan, where it has been
used to evaluate palliative interventions47,51,52 and to
explore the relationship between family-related fac-
tors, awareness of prognosis, and patient out-
comes.45,46,48 New countries in which POS use has
been documented since the last review include
Kenya,25,31,32,38 South Africa,16,19,24,32,34,38 Tanzania,17
Uganda,16,20,24,25,32 Zimbabwe,14 and Malawi.43 There
were no publications reporting on STAS use in a
new country or culture.Purpose of Administration of the POS or STAS
All articles were classified according to the study aim
(Fig. 2). These data were combined with those of the
previous review to present the overall categories of use
for the POS and STAS (Fig. 3).
Five studies validated English or translated versions
of the POS,24,26,27,40,44 whereas two reported factor
analysis of the measure.28,32 Eight articles validated
or used the POS in a new patient
group,6,18,23,25,26,29,30,33 whereas the same number re-
ported the validation or use of the POS in a new cul-
ture.14,16,17,20,29,31,34,43 Adaptations of the POS wereused in four studies.6,20,21,23 In five studies, the POS
was compared with other clinical measurement
tools.24,26e28,40 The POS helped to evaluate interven-
tions in 11 studies.14,29,34e39,41e43 Seventeen studies
reported use of the POS to assess symptom prevalence
or palliative care needs.6,11,12,15,16,18e23,25,29e31,33,38
One article studied the implementation of the POS
as an outcome measure,34 whereas eight compared
patient needs and outcomes in different palliative
care settings.13,15,17,19,36,37,39,41 One study compared
patients’ and professionals’ assessments.29 Profes-
sionals’ and informal caregivers’ views on the POS
were reported in one article.44 In four studies, the
POS was used by informal caregivers to assess
patients.13,14,29,41
Five studies used the STAS to evaluate an
intervention.47e49,51,52 Seven (all but one) of the
studies assessed the symptom prevalence among a pa-
tient population.45e48,50e52 One audited the imple-
mentation of the STAS as an outcome measure.49
There were no validation studies or studies using
the STAS in a new patient group, culture, or
translation.Methods of Data Collection
Most study data were collected in longitudinal
studies with data collected at multiple times,
0 2 4 6 8 10 12 14 16 18
ValidaƟon of original (English) or translated versions
Factor analysis of original (English) or translated versions
ValidaƟon / Use in a new paƟent group
ValidaƟon / Use in a new culture
Use of a translated version (not English)*
Use of an adapted version (e.g. with addiƟonal symptom quesƟons)
Comparison with other measures
EvaluaƟon of an intervenƟon
Study of symptom prevalence / assessment of palliaƟve care outcomes
Study of implementaton of outcome measures
Comparison of needs / outcomes in diﬀerent seƫngs
Comparison of assessment between paƟents and professional caregivers
RelaƟves' / Family carers' views on POS
Family carer assessment of paƟent
Study protocol STAS 2014
POS 2014
Fig. 2. Categories of use for POS and STAS publications 2010e2014. *Only those studies which clearly stated use of translated
versions shown; Non-English translations may be validated or nonvalidated. POS ¼ Palliative care Outcome Scale; STAS ¼
Support Team Assessment Schedule.
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(n ¼ 22).11,12,17e19,22,26,27,29e31,33e43 Cross-sectional
studies also were used; two for the STAS (both of which
used data mining methods)45,46 and 13 for the
POS.6,13,15,16,20,21,23,25,28,31,32,37,44 One POS study used
qualitative methods to determine the content and
construct validity of two items in the POS for African
palliative care populations.24 Two studies, which used
the measures as part of a project evaluation, were classi-
fied as audits; one using the POS14 and the other using
the STAS.490 2
Use of clinical scenarios
EvaluaƟon of support team / inpaƟent unit
PaƟents' views on POS
Professionals' views on POS
Comparison of assessment between paƟents and informal carer
ValidaƟon of original (English) or translated versions*
ValidaƟon of original (English)**
Factor analysis of original (English) or translated versions
ValidaƟon / Use in a new paƟent group
ValidaƟon / Use in a new culture
Use of a translated version (not English)*
ValidaƟon / Use of translated version**
Use of an adapted version (e.g. with addiƟonal symptom quesƟons)
Comparison with other measures
EvaluaƟon of an intervenƟon
Study of symptom prevalence / assessment of palliaƟve care outcomes
Study of implementaton of outcome measures
Comparison of needs / outcomes in diﬀerent seƫngs
Comparison of assessment between paƟents and professional caregivers
RelaƟves' / Family carers' views on POS
Family carer assessment of paƟent
Study protocol
Fig. 3. Total categories of use for POS and STAS publications u
articles since 2010 shown). **Old categorization from Bausewe
shown). POS ¼ Palliative care Outcome Scale; STAS ¼ SupportDiscussion
Following the initial, considerable contribution
made by the POS and STAS to palliative care, as re-
ported in the previous review,7 use and translation of
these tools has steadily increased. This is indicated
by a further eight articles using the STAS and 35 arti-
cles using the POS that were published since 2010.
During this time, the global reach of these outcome
measures has broadened, particularly in Africa, where
POS use has now been documented in six additional4 6 8 10 12 14 16 18 20 22 24 26
STAS
POS
p to 2014. *New categorization in 2010e2014 review (only
in et al. (2011) review (only articles before February 2010
Team Assessment Schedule.
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tions using the POS have come from the U.K., Ger-
many, The Netherlands, and Spain. These findings
are in line with a study by Harding et al.55 which found
that the POS was among the top five outcome mea-
sures used in research as well as clinical care and audit
in Europe. Similarly, Higginson et al.56 reported that
across Europe and Africa, the POS was among the
most common measures used by researchers and clini-
cians alike.
Patterns of use appear to have changed since the
last review. Although in the previous review most pub-
lished studies focused on validation of measures and
their translations, or use in new cultures, publications
since then have focused more on using the POS, and
to a lesser degree the STAS, particularly to study symp-
tom prevalence and evaluate interventions. This may
indicate that earlier validation work, as captured by
publications included in the previous review, has
now resulted in these measures being used as vali-
dated and reliable tools to capture symptoms and
needs. These findings are in line with a survey by Hig-
ginson et al.,56 which found that 88% of POS users
and 85% of STAS users used these measures to assess
patients’ symptoms and needs.
Despite this increase in use of the POS and STAS to
assess symptom burden, as evidenced by our results, a
recent systematic review found that several barriers
still exist that might limit the implementation of
outcome measures into routine clinical practice.57
Among these barriers are a lack of time, resources,
and training, as well as measure- and patient-specific
issues. Therefore, although the results of this study
indicate an increase in the use of these measures,
more could be done to support clinicians who wish
to implement outcome measures, such as the POS
(or STAS), in their clinical practice.
Studies investigating the validity of the POS
increased evidence for the validity of this measure.
Two studies reported the reliability and concurrent
validity of the measure, specifically of the core POS
and POS-S-MS.26,41 The importance of the ‘‘at peace’’
item to patients and bereaved relatives is confirmed by
two studies, as is the acceptability of the measure.24,44
However, one study reported that, among 10 measures
of perceived quality of dying and quality of care, the
POS had the least correlation with the other mea-
sures.27 It is unclear, however, whether this indicates
that the other measures were more or less reliable
than the POS. In combination with the POS validation
studies included in the previous review, there is a
growing body of evidence for the validity of the POS
and its acceptability among patients, caregivers, and
health professionals. We also were made aware of
ongoing work to develop and validate an IPOS, whichcombines items from the POS, POS-S, and the APCA
African POS (Appendix IV). However, no publications
were available about the IPOS at the time of this re-
view. Unfortunately, no further validation studies
were identified for the STAS.
In general, there appears to be greater popularity
for the POS than for the STAS, with more than four
times as many publications for the POS being pub-
lished over the last four years. This continues the
trend identified in the previous review, which also
identified more publications for the POS than the
STAS.7 In Africa, the extensive use of the POS is likely
linked to the endorsement of this measure by the
APCA, as well as the availability of several translated
versions.24,38,54,58 The reason for more frequent use
of the POS in other parts of the world might be linked
to the increasing popularity of PROMs over the years,
as the POS is predominantly a patient-completed mea-
sure. Particularly in Europe and the U.S., there has
been a push for increased use of PROMs in recent
years, which may have impacted the choice of mea-
sures, both for research and clinical use.59,60 However,
it is important to note that the POS also exists as a
staff-completed measure, as well as a carer-completed
measure. Although most studies included in this re-
view used the patient version, some only used the
carer version,13,15 or used several different
versions.12,41
Included studies did not report on comparisons be-
tween patient and proxy versions. Having completed
patient and proxy ratings available is valuable, as it en-
ables direct comparison of perceived severity of symp-
toms from patient and proxy perspectives. Future
psychometric studies should include testing of inter-
rater reliability, particularly between patient- and
staff-completed versions. Data on patient versus proxy
ratings support the validity of measures and ensure
the whole of the palliative care population can be
included.
Interestingly, the STAS appears to be more popular
in China and Japan, with 18 STAS publications overall
(including six new publications) from these countries,
compared to none for the POS. This may be explained
by the lack of fully validated translations of the POS in
Chinese or Japanese, although it is worth noting that
translation and validation of a Japanese POS is under-
way. It also may be a result of cultural differences and/
or different health care systems in these countries,
which may prefer a more paternalistic approach,
with health professionals taking the lead.61
The STAS and POS were both developed and vali-
dated originally in patients with advanced cancer.
This is still evident from the STAS publications, but
the growing use of the POS among other palliative
care populations was noted in the previous review,
850 Vol. 50 No. 6 December 2015Collins et al.and this has continued to be the case. There are now
numerous publications reporting the use of the POS
for patients with nononcological conditions; particu-
larly in patients with HIV/AIDS and neurological con-
ditions. This suggests that palliative needs are
beginning to be recognized among a variety of popu-
lations beyond those with cancer. In addition, new sub-
sets of previously explored patient populations are
now being included in studies, suggesting a growing
understanding of palliative needs along disease trajec-
tories and spectrums. Although most of these studies
focused on the use of the POS in noncancer popula-
tions, two studies reported the validation of the POS;
one in MS patients26 and another in dementia
patients.27
Multiple versions of the POS have been used in
studies, including the core POS, POS-S-MS, POS-S-
renal, POS-S-PP, and APCA African POS. In particular,
there has been wide use of the APCA African POS,
mostly for patient populations living with HIV/AIDS.
In the previous review, one validation study reported
a need for the POS to be better adapted to the needs
of patients with motor neuron disease,62 but use of the
POS-S-PP with this population of patients in two
studies18,23 suggests that improvements have been
made here.
Many new and older translations of the POS have
been used successfully for data collection in several
included studies.14,16,17,19,20,24,25,31,32,34,38 There have
been no new translations of the STAS, although the
Japanese,47,48,51,52 French,50 and Chinese45,46 transla-
tions have been in use. There are still several transla-
tions of both the POS and the STAS that have not
yet been formally validated, and future publications
may report on the validation and use of these transla-
tions. Therefore, periodic review of the literature on
the POS and the STAS in the future is recommended.Strengths and Limitations
This systematic review incorporated an extensive
search for relevant publications, including contacting
of subscribers to the POS website and scanning of
reference lists to complement the literature search.
The findings presented build on an established body
of evidence for the use of the POS and the STAS as
collated by Bausewein et al.7 Similarities in the find-
ings of these two reviews in terms of POS and STAS
use promote the reliability of our findings. In this re-
view, we counted number of studies rather than publi-
cations, to account for multiple reporting and
increase the accuracy of the reported results.
A limitation of this review is that it did not pick up
use of the POS and the STAS that was not reported in
the literature. As both tools are available for use in
clinical practice, the present review may somewhatunderestimate actual use by clinical teams, which
may use these measures to assess and monitor pa-
tients’ symptoms and needs to inform care.55,56 Other
limitations of this review include the fact that data
extraction was mainly performed by one researcher
(E. S. C.) and that only published studies were
included, although ongoing research that the authors
were aware of is outlined in Appendix IV. Finally,
several of the authors were involved in the initial
development and validation of the STAS and the
POS (C. B., I. J. H., F. E. M. M.), which may somewhat
bias them toward a more positive assessment of these
measures. However, the range of identified publica-
tions from teams not associated with the authors sup-
ports the findings that these tools are acceptable and
useful.Conclusion
Overall, the present review shows that the POS, and
to a lesser extent the STAS, has continued to be used
in a variety of settings and countries since the last re-
view was published. POS use has particularly increased
in Europe and Africa, with 12 new African translations.
In Asia, use of the STAS is more common. Both mea-
sures are now more frequently used in studies that
assess symptoms and needs, rather than validation
studies, which may be an indication that they are
now perceived as reliable and valid tools that can be
used for these purposes without the need for further
validation. Owing to this widespread use, particularly
the POS and to a lesser degree the STAS may be
used in the future to compare data internationally
and/or to compare symptoms and needs in different
disease groups, especially diverse palliative care popu-
lations with a range of malignant and nonmalignant
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Search Strategy
Search Terms
‘‘Support team assessment schedule’’
‘‘STAS and palliative’’
‘‘Palliative care outcome scale’’
‘‘Palliative outcome scale’’
‘‘Patient outcome scale’’
‘‘POS and palliative’’CINAHL
Abstract search. January 2010eJune 2014. Each phrase/term searched for separately and then combined with
OR.
47 records identified.British Nursing Index
Abstract search. After January 1, 2010. Each phrase/term searched for separately and then combined with OR.
13 records identified.Ovid (MEDLINE, Embase, and PsycInfo)
Keyword search.
1) Support team assessment schedule
2) STAS AND palliative
3) Palliative care outcome scale
4) Palliative outcome scale
5) Patient outcome scale
6) POS AND palliative
7) 1 OR 2 OR 3 OR 4 OR 5 OR 6
8) Limit (7) to yr ¼ ‘‘2010-current’’
9) Remove duplicates from (8)
118 records identified.
Appendix II
Data Extraction
Number Year
Authors (First
and Last) Country
Population,
Sample Size Purpose Study Design Study Focus Result
Additional
Comments or
Notes (e.g.,
Versions Used)
Overview of POS publications
1 2012 Afshar M. and
Mamode N.
U.K. 110 renal
transplant
patients who
received
transplant
at least one yr
before study.
Use Cross-sectional To identify symptom
prevalence, severity,
and total symptom
burden in renal
transplant patients,
whether symptom
clusters existed, and
the relationship of
symptoms to
comorbidity and
renal function.
Symptom burden
was high among
patients and
included weakness,
difficulty sleeping,
dyspnea, feeling
anxious, and
drowsiness.
Significant inverse
relationship
between renal
function and
number of
symptoms, and
between time since
transplant and
number of
symptoms emerged.
Used modified
version of
POS-S-renal,
which had not
been validated
in patient
population.
2 2010 Bausewein C. and
Higginson I.
Germany 49 patients
with lung
cancer, 60
patients with
COPD.
Use Prospective
longitudinal
(baseline,
monthly over
6 months or
until death)
To describe and
compare the
summary and
individual
trajectories of
breathlessness and
overall symptom
burden over time
and toward the end
of life following
patients with
advanced cancer or
COPD in inpatient
and outpatient
healthcare settings.
POS used to assess
patient-reported
palliative care
needs.
Breathlessness
increased over time
for COPD patients,
whereas
breathlessness
increased toward
death for cancer
patients. Four
patterns of
individual
breathlessness
trajectories:
fluctuation,
increasing, stable,
and decreasing.
German POS
used.
3 2011 Bookbinder M. and
Portenoy R. K.
U.S. 114 patients living
at home with
varying diagnoses
receiving palliative
care from one of
two nurse
practitionerebased
services.
Use Longitudinal To evaluate the
financial
sustainability and
feasibility of two
nurse practitionere
based models in an
urban setting. POS
used to assess
High burden of
medical and
instrumental need
documented by
POS. Hospice-based
nurse practitioner
model was shown to
be sustainable in an
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and Last) Country
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Sample Size Purpose Study Design Study Focus Result
Additional
Comments or
Notes (e.g.,
Versions Used)
patient-reported
palliative care needs
in one of the two
programs.
urban
environment.
4 2012 Cohen L. W. and
Zimmerman S.
U.S./The
Netherlands
Family caregivers of
196 residents with
dementia who had
died (U.S. ¼ 126,
The
Netherlands ¼ 70).
Use Interviews and
self-administered
questionnaires
To examine cross-
national care and
outcomes related to
end-of-life
experiences.
U.S. caregivers
reported better care
and outcomes, and
better quality of
care in the last
3 days of life;
caregivers in The
Netherlands
reported better
quality of life in the
last month and
3 days of life.
Unclear
whether
Dutch
translation
was used in
The Netherlands
or not.
5 2010 Defilippi K. M. and
Cameron S.
South Africa Four community-
based organizations
which run HIV/
AIDS-related
programs: 30
caregivers and 24
patients with
advanced disease
completed the
African Palliative
Care Association
POS (APCA POS).
Use Assessment of pilot
project
To assess the impact
of a model of
introducing a
palliative care
component and
professional
supervision of
community
caregivers on the
quality of care given
to people living
with HIV/AIDS and
their families.
African Palliative
Care Association
POS (APCA POS)
was used to assess
the level of care
provided by the
organization
through impact on
patients and
families.
African Palliative Care
Association POS
(APCA POS) was
relevant assessment
score. Average
improvement of
caregivers scores by
28.5%. The reach of
professional
palliative care
supervision can be
expanded beyond
hospice boundaries.
African Palliative
Care Association
POS (APCA POS).
Scores summarized
into graph.
6 2010 Di Sorbo P. G. and
Williams S. H.
Zimbabwe Project targets 1013
patient households.
Use Project report To assess the
implementation of
the Zimbabwe
Rural Palliative
Care Initiative,
which aimed to add
palliative care to
Palliative care model
appears well suited
for Zimbabwean
context. Follow-up
needed on baseline
POS figures.
APCA POS. Report
of project set up
with no evaluation.
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existing home-
based care teams
comprising
indigenous rural
volunteers.
7 2010 Gomes B. and
Higginson I. J.
U.K. Bereaved relatives of
adults who died
from cancer in a
1 yr period.
Use Mortality follow-
back postal
survey with
nested case-
control study
of home vs.
hospital deaths
To examine variations
in the quality and
costs of end-of-life
care, preferences,
and palliative
outcomes
associated with
home vs.
institutional death
in cancer.
[Protocol]
8 2013 Gomes B. and
Higginson I. J.
U.K. 20 bereaved relatives
of cancer patients.
Validation Cross-sectional To improve the
measurement of
health outcomes
and care utilization
at the end of life for
bereaved relatives.
Bereaved relatives
able to understand
most of the
questions despite
finding them
demanding and
intense. Adaptation
of POS to foster
participant
understanding and
include peace item.
Preparation for
QUALYCARE
study.
9 2013 Groh G. and
Borasio G. D.
Germany 60 patients treated by
Specialized
Outpatient
Palliative Care
service and their
primary caregivers.
Use Prospective To evaluate the
acceptance and
effectiveness of an
SOPC team as
perceived by
patients and
caregivers.
POS and QoL scores
of patients and
caregivers improved
significantly over
time through
involvement with
SOPC team;
reduced burden of
home care for
caregivers.
Not primary
outcome.
German POS
used.
10 2012 Harding R. and
Higginson I. J.
South Africa/
Uganda
230 patients with HIV
across five palliative
care sites.
Use Cross-sectional To determine the
intensity of
multidimensional
problems in a three
day period among
HIV patients
receiving integrated
palliative care in
sub-Saharan Africa
and to identify
associations with
problem severity.
Most burdensome
problems were
pain, worry,
symptoms, and
adequate
information to plan
for the future.
Patients receiving
home care may
require additional
support to enhance
wellbeing.
APCA POS and
versions in
African languages
used.
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11 2013a Harding R. and
Powell R. A.
Kenya/
South Africa/
Uganda
1337 patients with
HIV across 12
PEPFAR sites.
Factor analysis Secondary analysis
of cross-
sectional data
To determine which
specific factors
underpin the APCA
African POS to
assist the analysis of
data in routine
clinical care and
audit.
Confirmatory factor
analysis: three-
factor solution of 1)
physical and
psychological
wellbeing, 2)
interpersonal
wellbeing, and 3)
existential
wellbeing. Factors
map well to
palliative care goals
and enable audit.
APCA POS and
versions in
African
languages used.
12 2013b Harding R. and
Loy G.
Tanzania 120 patients at an HIV
outpatient center
Use Prospective
longitudinal
(baseline, then
fortnightly until
Week 10)
To evaluate, in terms
of patient
outcomes, palliative
care delivered by
the existing HIV
outpatient clinical
personnel in
Tanzania,
compared to
standard HIV
outpatient care.
Significantly lower
reported pain and
improved POS
scores in palliative
care site when
delivered alongside
ART, regardless of
prognosis.
APCA POS.
13 2014 Harding R. and
Higginson I.J.
Kenya 548 HIV patients
across five sites
Use Cross-sectional To identify what
proportion of HIV
outpatients has a
CD4 result present
in their clinical
records, and to
examine which
characteristics are
associated with the
presence of a CD4
result.
Lack of CD4 result
associated with
antiretroviral use,
facility, poverty,
prevalence of
multidimensional
problems, and
education level.
Inconsistencies in
results.
APCA POS.
14 2012 Hermann K. and
Miksch A.
Germany 100 cancer patients
receiving palliative
care and 45 General
Practitioners (GPs);
27 trained in
palliative care by a
regional training
initiative, 18
controls.
Use Longitudinal
(baseline,
monthly over
6 months or
until death)
To evaluate if
palliative patients of
GPs trained in
palliative care have
a better health-
related Quality of
Life (QoL).
Patients cared for by
palliative-trained
GPs did not report
better QoL and
care outcomes than
patients cared for
by other GPs.
German POS used.
(Continued)
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Number Year
Authors (First
and Last) Country
Population,
Sample Size Purpose Study Design Study Focus Result
Additional
Comments or
Notes (e.g.,
Versions Used)
15 2011 Higginson I. J. and
Edmonds P.
U.K. 52 patients severely
affected by multiple
sclerosis.
Use RCT fast-track
Phase II
longitudinal.
To determine (1)
whether the timing
of referral to the
short-term palliative
care team (three
months earlier) had
an impact on
longer term
outcomes, and (2)
the potential staff-
modifying effect of
the short-term
palliative care
intervention.
Receiving palliative
care earlier has a
similar effect on
reducing symptoms
but greater effects
on reducing
caregiver burden,
compared to later
referral. The
palliative care
intervention has an
effect after
withdrawal for six
weeks before
waning.
16 2012 Higginson I. J. and
Leigh N.
U.K. 82 patients with
idiopathic
Parkinson disease,
progressive
supranuclear palsy,
or multiple system
atrophy.
Use Longitudinal
(baseline, then
three times over
one yr)
To determine how
symptoms and
quality of life of late
stage Parkinson
syndrome patients
change over time;
and what
demographic and
clinical factors
predicted changes.
Profound and
complex mix of
nonmotor and
motor symptoms in
patients. Symptoms
are not resolved
and half of patients
deteriorate. Early
palliative
assessment is
predictive of future
symptoms.
POS-PP (for
Parkinson) and
core POS. Same
data set as Saleem
et al. (2013)
17 2011 Hongoro C. and Dinat
N.
South Africa 72 patients to
palliative care
service completed
POS. Cost analysis
of N’Doro Palliative
Care pilot at Chris
Hani Baragwanath
Hospital
Use Cost accounting
procedured
APCA POS
applied at five
intervals in two
months
To establish the costs
and cost drivers for
a hospital outreach
palliative care
service in a low-
resource setting,
and to elucidate
possible
consequential cost
savings.
Some of the POS of a
subsample showed
statistically
significant
improvements.
Outreach visits cost
50% less than the
average cost of a
patient day
equivalent for
district hospitals.
APCA POS. Unclear
which translation(s)
used.
18 2012 Lewington J. and
Harding R.
Uganda 78 hospital inpatients
with active life-
limiting disease.
Use Cross-sectional
(census and
interviews)
To measure the
magnitude of
palliative care needs
among hospital
inpatients.
Prevalence of active
life-limiting disease
here (46%) is
greater than in
comparable
European studies
APCA POS and
versions in African
languages used.
(Continued)
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Number Year
Authors (First
and Last) Country
Population,
Sample Size Purpose Study Design Study Focus Result
Additional
Comments or
Notes (e.g.,
Versions Used)
(5%e23%). POS
revealed
multidimensional
need in 96% of
patients.
19 2012 Lowther K. and
Harding R.
Kenya/
South Africa
240 patients with HIV
who have been
receiving ART for
one month.
Use RCT To assess the
effectiveness of
palliative care for
HIV outpatients on
antiretroviral
treatment.
[Protocol] APCA POS and
versions in African
languages used.
20 2013 Malik F.A. and
Higginson I. J.
U.K. 51 heart failure and
50 lung cancer
patients
experiencing
breathlessness on
day-to-day basis,
plus 101 caregivers.
Use Cross-sectional,
descriptive,
comparative
To compare
experiences of
caring for a
breathless patient
with lung cancer
versus those with
heart failure and to
examine factors
associated with
caregiver burden
and positive caring
experiences.
Severity of patient
breathlessness and
caregiver concerns
similar across both
groups.
POS-S and core POS.
21 2013 Molina E. H. and
Media J. F. O.
Spain 1478 oncology
patients with a
malignant
neoplasm.
Use Longitudinal
prospective
To analyze whether a
programme of
social intervention
in palliative care
results in a
reduction in the
consumption of
healthcare
resources and cost
by end-of-life
patients and
promotes a shift
toward a more
community-based
model of care.
[Protocol] Spanish POS used.
22 2011 Murtagh F. E. M.
and Higginson I. J.
U.K. 74 patients with Stage
5 chronic kidney
disease managed
without dialysis.
Use Longitudinal To describe, for
patients with Stage
5 chronic kidney
disease managed
conservatively
(without dialysis),
the trajectory of
symptoms and
Moderate symptom
distress and health-
related concerns,
with marked
increase in the last
two months of life.
Related to article by
Murphy et al.
(2009), included in
previous review.
(Continued)
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and Last) Country
Population,
Sample Size Purpose Study Design Study Focus Result
Additional
Comments or
Notes (e.g.,
Versions Used)
patient health-
related concerns
over the last year of
life.
23 2013 Nkhoma K. and
Arthur A.
Malawi People living with
HIV/AIDS and
their carers.
Use Longitudinal To evaluate the effect
of an educational
intervention for
patients with HIV/
AIDS and their
family carers.
Study protocol. APCA
POS in Tumbuka
translation used.
24 2013a Pelayo-Alvarez M.
and Agra-Varela Y.
Spain 145 palliative care
professionals; 124
corresponding
patients; 48
caregivers.
Use Longitudinal (case
control)
To test the clinical
effectiveness of
online palliative
care education of
physicians through
impact on symptom
control, quality of
life, caregiver
satisfaction, and
knowledge-attitude
of physicians at
18 months of the
intervention.
Participation in
educational
program improved
patient scores for
some symptoms and
family anxiety on
POS.
Spanish POS used.
Related to Pelayo-
Alvarez M. et al.,
2013b.
25 2013b Pelayo-Alvarez M. and
Agra-Varela Y.
Spain 117 outpatients with
advanced cancer.
Validation Longitudinal
(baseline þ 7/
10 days)
To investigate the
reliability and
concurrent validity
of POS, the
Rotterdam
Symptom Checklist
(RSCL), and the
Brief Pain Inventory
(BPI).
Significant
correlations and
agreement between
the three measures.
Adequate reliability
and moderate
concurrent validity
among POS, RSCL,
and BPI.
Spanish POS used.
Related to Pelayo-
Alvarez M. et al.,
2013a.
26 2012 Saini A. and Berruti A. Italy 123 advanced cancer
patients being
treated with major
opioids for severe
chronic pain.
Use Longitudinal
prospective
(7 days)
To determine whether
breakthrough
cancer pain (BTP)
has a circadian
rhythm and to
correlate patterns
of BTP occurrence
with diminished
QoL.
BTP episodes showed
a circadian pattern,
and were negatively
correlated with
QoL.
Italian POS used.
27 2013 Saleem T. Z. and
Leigh N.
U.K. 82 patients with
idiopathic
Parkinson disease,
progressive
supranuclear palsy,
Use Cross-sectional To assess symptom
prevalence, severity,
and palliative care
needs in advanced
stages of
Burden of symptoms
high in advanced
stages of disease.
Symptoms causing
severe problems
Core POS and POS-
PD used as an
adapted version of
POS-S. Same data
set as Higginson I.
(Continued)
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Sample Size Purpose Study Design Study Focus Result
Additional
Comments or
Notes (e.g.,
Versions Used)
or multiple system
atrophy
Parkinsonism. were pain, fatigue,
constipation, and
drooling. Moderate
palliative care
needs.
J., Gao W., Saleem
T. Z. et al., 2012
28 2013 Selman L. and
Harding R.
South Africa/
Uganda
Palliative care
patients; 72 for
interviews, 285 for
quantitative data
collection.
Validation Validation (mixed
methods)
To determine the
content and
construct validity of
POS items relating
to ‘‘peace’’ and ‘‘life
worthwhile’’ as
measures of
spiritual wellbeing
in African palliative
care populations.
‘‘Peace’’ and ‘‘life
worthwhile’’ are
useful POS items as
distinct but related
measures of
spiritual wellbeing.
Correlations with
Spirit 8 items were
weak to moderate.
APCA POS and
versions in African
languages made
and partially
validated (isiXhosa,
isiZulu, SeSotho,
SeTswana,
Luganda,
Runyoro).
29 2013 Simms V. and Harding
R.
Kenya/Uganda 438 patients recently
diagnosed with
HIV.
Use Cross-sectional To determine for the
first time the
prevalence and
severity of
multidimensional
problems in a
population newly
diagnosed with HIV
at outpatient clinics
in Africa.
Most prevalent
problems
were lack of
help and advice
and difficulty
sharing feelings.
Limited physical
function associated
with more
physical/
psychological and
existential
problems
but fewer
interpersonal
problems.
APCA POS and
versions in African
languages used.
30 2013 Sleeman K. E. and
Higginson I. J.
U.K. 46 patients with
multiple sclerosis
and palliative care
needs.
Validation Secondary analysis
of longitudinal
data
To assess the
psychometric
properties of core
POS and POS-MS-S
(for symptoms in
multiple sclerosis)
in patients severely
affected by MS.
Missing data were low,
and floor and
ceiling effects were
absent. Good
internal
consistency.
Construct validity
was consistent. Core
POS and POS-MS-S
are acceptable,
reliable, and valid.
Core POS and POS-
MS-S
31 2014 Slort W. and Deliens
L.
The Netherlands 126 GPs and 157
patients with
advanced illness.
Use Longitudinal To report outcomes
reported by patients
who received
No significant effects
of training
programme on
Dutch POS used.
(Continued)
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Additional
Comments or
Notes (e.g.,
Versions Used)
palliative care of
GPs who
participated in the
Availability, Current
issues and
Anticipation
training
programme.
patient-reported
outcomes
(including POS).
32 2012 van Soest-Poortvliet
M. C. and
de Vet H. C. W.
The Netherlands 70 family members
and 103 healthcare
professionals of 119
long-term care
decedents with
dementia.
Validation Longitudinal
(prospective
and retrospective)
To assess and
compare the
validity and
reliability of 10
measures of
perceived quality of
care and quality of
dying for residents
dying with
dementia in
nursing homes and
residential care
homes.
Instruments within
the constructs of
quality of care and
quality of dying
were highly
correlated. POS
performed worst in
this population.
Dutch POS used.
33 2011 van Soest-Poortvliet
M. C. and de Vet H.
C. W.
The Netherlands Instruments assessing
quality of care/
dying for dementia
population in long-
term care settings.
Validation Qualitative content
analysis
To evaluate the
content of available
measurement
instruments to
assess the quality of
dying and care
when dying.
Instruments differed
and most do not
measure a single
construct. POS
measured quality of
dying (70%),
process of care
(20%), and
satisfaction with
health care (10%).
Dutch POS used.
34 2012 Vincent S. U.S. 10 heart failure
patients, seven
caregivers, and
health
professionals.
Use Longitudinal To determine factors
influencing
worsening
symptoms of heart
failure (HF) in
elder HF patients
and to examine
POS functional
scores following
distribution of an
HF management
tool.
Significant differences
in reporting of pain
and symptoms
between health
professionals and
patients, suggesting
that worsening
symptoms were not
being recognized by
HPs.
PhD thesis.
35 2014 Weingaertner V. and
Simon S. T.
Germany 82 patients with
Chronic
Obstructive
Use Longitudinal To describe and
compare the
courses of
The palliative care
needs of patients
with advanced
German POS used.
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Versions Used)
Pulmonary Disease
(COPD) Stage III
or IV, or primary
lung cancer.
refractory
breathlessness,
functional status,
distress, and
palliative care needs
in patients with
advanced COPD or
lung cancer over
time.
COPD are
comparable with
lung cancer
patients, and
breathlessness
severity and distress
are even higher.
Overview of STAS publications
1 2011 Chan W. C. H.1 China
(Hong Kong)
Clinical records of 935
deceased
cancer patients in a
hospital palliative
care unit between
2003 and 2005.
Use Data mining To explore the
relationships
among patients’
awareness of
prognosis, family
members’
awareness of
prognosis, and two
psychosocial
outcomes of
patients: patients’
anxiety and
communication
with family
members.
Patients who did not
have a clear idea of
their prognosis
were more likely to
experience anxiety
and difficulty
communicating
with family
members.
Not primary outcome
measure.
Chinese version of
STAS.
2 2012 Hashimoto T. and
Endou T.
Japan Four esophageal
cancer patients who
underwent salvage
surgery to reduce
gastric stenosis/
obstruction
following
unsuccessful
chemotherapy.
Use Case series To examine the
impact of salvage
surgery on QoL in
patients who were
unsuccessfully
treated with
chemotherapy.
STAS-J scores
improved for three
of four patients who
received salvage
surgery.
Japanese version of
STAS.
3 2013 Murakami H. and
Yamaguchi Y.
Japan 27 patients
hospitalized with
malignant
gastrointestinal
obstruction.
Use Longitudinal
(retrospective
cohort)
To investigate
improvements in
symptoms caused by
gastrointestinal
obstruction
following
administration of
octreotide acetate
injection in
combination with
steroid and opioid
administration.
Response rate of
77.8%. Intravenous
administration of
octreotide acetate
with steroid can
effectively improve
gastrointestinal
symptoms without
adverse events.
Japanese version of
STAS. Scores not
reported directly
but included in
regression analyses.
(Continued)
8
5
3
.e1
1
V
ol.
5
0
N
o.
6
D
ecem
ber
2
0
1
5
C
ollin
s
et
al.
Appendix II
Continued
Number Year
Authors (First
and Last) Country
Population,
Sample Size Purpose Study Design Study Focus Result
Additional
Comments or
Notes (e.g.,
Versions Used)
4 2012 Nakajima N. and
Ishida M.
Japan 87 terminally ill
cancer patients who
died during a 27
month period.
Use Longitudinal
(retrospective
cohort)
To examine the
relationship
between informing
patients of cancer
and the quality of
terminal care.
Informing patients of
more specific
information will
increase the quality
of terminal care
regarding patient
anxiety, recognition
of disease
conditions, and
level of
communication.
Japanese version of
STAS.
5 2011 Sutherland J. and
Stananought N.
U.K. 50 patients/
healthcare
professionals/
caregivers who had
previously
contacted the
telephone triage
team.
Use Audit (retrospective) To determine the
ability of a
telephone triage
team to either
reduce patients’
STAS scores that
were rated three or
more on a
telephone
assessment, or to
refer them to the
appropriate service.
60% of STAS scores of
over three had
improved by second
telephone contact.
Telephone triage
team has same
impact as
community
palliative care team;
can provide high-
quality palliative
care.
6 2011 Vassal P. and
Chapuis F.
France 146 hospitalized
patients at the end
of life who wanted
to return home.
Use Longitudinal To clarify the
influence of the
overall vulnerability
of patients, family,
and caregivers on
the return home.
Patients’ overall
vulnerability had a
significant
influence on the
return home;
applied in 40% of
clinical cases and
made possibility of
return home 50%
less likely.
French version of
STAS.
7 2013 Yamaguchi S. and
Korogi Y.
Japan 133 patients treated
with palliative
radiotherapy with a
poor performance
status at the
beginning of
treatment.
Use Longitudinal To evaluate the
palliative effect,
assessed by the
second item of
STAS, and
tolerability of
palliative radiation
therapy in patients
with a poor
performance status
and to analyze the
relationship
between the
Improvement in STAS
scores for 61%
patients, significant
improvement in
mean. Most
statistically
significant
prognostic factor
for overall survival
time after
radiotherapy. Low
rates of acute
toxicities.
Only second item of
the STAS used.
Japanese version of
STAS.
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Versions Used)
palliative effect and
the survival time.
8 2012 Chan W. C. H. and
Epstein I.2
China
(Hong Kong)
638 deceased cancer
patients.
Use Data mining To operationalize and
assess the
percentage of
‘‘good deaths’’
achieved among
Chinese cancer
patients in a
palliative care
programme, and
the relationship of a
good death with
other factors.
21.5% of patients had
a good
deathdthese
patients were
significantly older,
in palliative care
longer, indicated
fullness of life and
had caregiver
acceptance and
support.
Chinese version of
STAS.
POS ¼ Palliative care Outcome Scale; RCT ¼ randomized controlled trial; ART = antiretroviral therapy; SOPC = specialized outpatient palliative care.
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Categories of Use
POS
Afshar M.
2012
Bausewein
C. 2010
Bookbinder
M. 2011
Cohen
L. W. 2012
Defilippi
K. 2010
Di Sorbo
P. 2010
Gomes B.
2010
Gomes
B. 2013
Groh G.
2013
Harding R.
2012
Harding R.
2013a
Validation of original
(English) or
translated versions
X
Factor analysis of
original (English) or
translated versions
X
Validation/use in
a new patient
group
Kidney disease
(transplant
patients)
Validation/use in a
new culture
South Africa Zimbabwe Kenya, South
Africa, Uganda
Use of a translated
version (not
English; only
those studies
which clearly
stated use of
translated
versions
included)
German German Luganda,
Runyankole,
SeSotho,
Runyoro,
SeTswana,
isiXhosa, isiZulu
Gauteng,
KwaZulu Natal
dialects
Use of an adapted
version of
original (English)
measure
POS-S-renal þ
9 items
Comparison with
other tools
Evaluation of an
intervention
X X X
Study of symptom
prevalence/
assessment
X X X X X
Study of
implementation of
outcome measures
X
Comparison of needs/
outcomes in
different palliative
care settings
X X
Comparison of
assessment between
patients/professional
caregivers
Professionals’ views
on POS
Relatives’/carers’
views on POS
X
Carer assessment of
patient
X X
Patients’ views on POS
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POS
Afshar M.
2012
Bausewein
C. 2010
Bookbinder
M. 2011
Cohen
L. W. 2012
Defilippi
K. 2010
Di Sorbo
P. 2010
Gomes B.
2010
Gomes
B. 2013
Groh G.
2013
Harding R.
2012
Harding R.
2013a
Study protocol X
Longitudinal X X X X
Cross-sectional X X X X X X
Qualitative
Quality assurance
(audit)
X
POS
Harding
R. 2013b
Harding
R. 2014
Hermann K.
2012
Higginson
I. 2011
Higginson
I. 2012
Hongoro
C. 2011
Lewington
J. 2012
Lowther
K. 2012
Malik F. A.
2013
Molina E. H.
2013
Murtagh F. E. M.
2011
Validation of
original (English)
or translated
versions
Factor analysis of
original (English)
or translated
versions
Validation/use in a
new patient
group
Parkinson
syndromes
Kidney disease
(Stage 5 chronic
kidney disease)
Validation/use in a
new culture
Tanzania Kenya Uganda
Use of a translated
version (not
English; only
those studies
which clearly
stated use of
translated versions
included)
Swahili German Seven local
languages in
Uganda
(unspecified)
Kiswahili,
isiXhosa,
Afrikaans
Spanish
Use of an adapted
version of
original (English)
measure
African Palliative
care Association
POS (APCA
POS) plus
seven items
Core POS
and POS-S
plus two
items from
POS-S-
neurological
Comparison with
other tools
Evaluation of an
intervention
X X X X
Study of symptom
prevalence/
assessment
X X X X X X X
Study of
implementation
of outcome
measures
Comparison of X X X X X
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POS
Harding
R. 2013b
Harding
R. 2014
Hermann K.
2012
Higginson
I. 2011
Higginson
I. 2012
Hongoro
C. 2011
Lewington
J. 2012
Lowther
K. 2012
Malik F. A.
2013
Molina E. H.
2013
Murtagh F. E. M.
2011
needs/outcomes
in different
palliative care
settings
Comparison of
assessment
between
patients/
professional
caregivers
Professionals’ views
on POS
Relatives’/carers’
views on POS
Carer assessment of
patient
Patients’ views on
POS
Study protocol X X
Longitudinal X X X X X X X X
Cross-sectional X X X
Qualitative
Quality assurance
(audit)
POS
Nkhoma
M. 2013
Pelayo-Alvarez
M. 2013a
Pelayo-Alvarez
M. 2013b
Saini
A. 2012
Saleem
T. Z. 2013
Selman
L. 2013
Simms
V. 2013
Sleeman
K. E. 2013
Slort W.
2014
van Soest-P.
2012
van Soest-P.
2011
Vincent S.
2012
Weingaertner V.
2014
Validation of original
(English) or
translated
versions
X (Spanish) X (African
dialects)
X X (Dutch)
Factor analysis of
original
(English) or
translated
versions
X (Dutch)
Validation/use in a
new patient
group
Parkinson
disease
HIV (newly
diagnosed)
MS (severely
affected)
Heart
failure
COPD
(advanced)
Validation/use in a
new culture
Malawi U.S.
Use of a translated
version (not
English; only those
studies which
clearly
stated use of
translated
versions included)
Tumbuka Spanish Italian Swahili, Luo,
Luganda,
Runyakitara
Dutch German
Use of an adapted
version of original
(English)
POS-PDd
adapted
from
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POS
Nkhoma
M. 2013
Pelayo-Alvarez
M. 2013a
Pelayo-Alvarez
M. 2013b
Saini
A. 2012
Saleem
T. Z. 2013
Selman
L. 2013
Simms
V. 2013
Sleeman
K. E. 2013
Slort W.
2014
van Soest-P.
2012
van Soest-P.
2011
Vincent S.
2012
Weingaertner V.
2014
measure POS-MS
Comparison with
other tools
X X X X X
Evaluation of an
intervention
X X X X
Study of symptom
prevalence/
assessment
X X X X X
Study of
implementation
of outcome
measures
Comparison of
needs/
outcomes in
different
palliative care
settings
X
Comparison of
assessment
between patients/
professional
caregivers
X
Professionals’ views
on POS
Relatives’/carers’
views on POS
Carer assessment of
patient
X X
Patients’ views on
POS
Study protocol X
Longitudinal X X X X X X X X X
Cross-sectional X X
Qualitative X X
Quality assurance
(audit)
STAS
Chan W. C. H.
2011
Hashimoto
2012
Murakami H.
2013
Nakajima N.
2013
Sutherland J.
2011
Vassal P.
2011
Yamaguchi S.
2013
Chan W. C. H.
2012
Validation of original
(English) or translated
versions
Validation/use
in a new patient group
Validation/use in a new
culture
Use of a translated version
(not English; only those
studies which clearly
Chinese Japanese Japanese Japanese French Japanese Chinese
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STAS
Chan W. C. H.
2011
Hashimoto
2012
Murakami H.
2013
Nakajima N.
2013
Sutherland J.
2011
Vassal P.
2011
Yamaguchi S.
2013
Chan W. C. H.
2012
stated use of translated
versions included)
Use of an adapted
version of original
(English) or translated
measure
Modified
for inpatient
care use
‘‘Adapted version’’
with additional
symptom detail
Only
second
item of
STAS used
Comparison with other tools
Evaluation of an
intervention
X X X X X
Evaluation of support team/
inpatient unit
Study of symptom
prevalence/symptom
assessment
X X X X X X X
Study of implementation of
outcome measures
X
Comparison of needs/
outcomes in
different palliative care
settings
Comparison of assessment
between patients/
professional caregivers
Use of clinical scenarios
Longitudinal X X X X
Cross-sectional X X
Qualitative
Quality assurance (medical
records and audit)
X
POS ¼ Palliative care Outcome Scale; STAS ¼ Support Team Assessment Schedule.
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Appendix IV
Ongoing Studies
Author(s) Type of Study Purpose of POS
Population/
Sample Size Focus
Murtagh F. E. M.,
Higginson I. J. H.,
Bausewein C.
Cognitive interviewing Development 10 U.K. patients, 15
German patients
To develop and test items in
a new outcome measure
called the Integrated
Palliative care Outcome
Scale (IPOS)
Murtagh F. E. M.,
Higginson I. J. H.,
Bausewein C.
Psychometric testing Validation Approximately 400
patients in total
from U.K. and
Germany
To fully validate the IPOS
measure
Dobrina R. Action research project Validation (choosing
an assessment tool
for future use)
20 members of the
hospice team
To develop and to evaluate
the impact of an advanced
and personalized caring
model in an Italian hospice
to improve patient
centered care
Raj R. Longitudinal (two POS
measurements)
Use 50e100 outpatients
on dialysis
Correlations of renal dialysis
with QoL
Secchi M. and Villa G. Longitudinal (baseline þ 2
measurements)
Use 324 cancer patients
and 13 nurses
To investigate quality of life
perception by patients and
nurses working and living in
Milan San Raffaele Hospital
day hospital environment
POS ¼ Palliative care Outcome Scale; APCA ¼ African Palliative Care Association; QoL ¼ Quality of Life.
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9Country Comment
U.K. and
Germany
The IPOS is a new outcome
measure that combines items
from the POS, POS-S, and
APCA African POS
U.K. and
Germany
The IPOS is a new outcome
measure that combines
items from the POS, POS-S,
and APCA African POS
Italy Two yr study. Italian translation
of POS
Tasmania,
Australia
POS-renal. POS administered
by nurses and self-completed
by patients
Italy Italian translation of POS
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